- Pharmaceutical companies
- Gilead Sciences
Gilead Sciences
Phone: +16505743000, 800-GILEAD-5 (800-445-3235)
Fax: (650) 578-9264
E-mail: public_affairs@gilead.com, corporate_development@gilead.com
Type | Public |
---|---|
Traded as |
|
Industry |
|
Founded | June 22, 1987 (1987-06-22) |
Headquarters | Foster City, California, United States |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$27.31 billion (2021) |
Operating income | US$9.92 billion (2021) |
Net income | US$6.23 billion (2021) |
Total assets | US$67.95 billion (2021) |
Total equity | US$21.06 billion (2021) |
Number of employees | 14,400 (2021) |
At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Through bold and transformative science, we’re creating possibilities that have the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.
For detailed contact information visit location pages below.
Gilead Sciences's locations around the world
Europe
North America
Africa
Oceania
Clinical Trials sponsored by Gilead Sciences
-
Gilead SciencesAún no reclutando
-
Gilead SciencesReclutamiento
-
Gilead SciencesReclutamientoColitis ulcerosaEstados Unidos
-
Gilead SciencesReclutamientoTumores sólidosAustralia, Estados Unidos, Canadá
-
Gilead SciencesReclutamientoInfección crónica por hepatitis DEstados Unidos
-
Gilead SciencesReclutamientoInfección crónica por hepatitis DAustria, España, Francia, Alemania, Rumania
-
Gilead SciencesReclutamientoInfección por VIH-1Estados Unidos, Tailandia, República Dominicana
-
Gilead SciencesActivo, no reclutandoCáncer colorrectal metastásicoEstados Unidos, España, Australia, Hong Kong, Francia, Bélgica, Canadá, Puerto Rico, Alemania, Italia
-
Gilead SciencesTerminadoLeucemia mieloide agudaEstados Unidos, España, Alemania, Israel, Reino Unido, Taiwán, Corea, república de, Australia, Bélgica, Hong Kong, Francia, Países Bajos, Italia, Canadá, Austria, Chequia, Hungría, Noruega, Polonia, Suiza
-
Gilead SciencesActivo, no reclutandoTumor sólido metastásicoEstados Unidos, España, Francia, Hong Kong, Australia, Bélgica, Taiwán, Canadá